|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Su SY, Huang JY, Ho CC and Liaw YP:
Evidence for cervical cancer mortality with screening program in
Taiwan, 1981–2010: Age-period-cohort model. BMC Public Health.
13:132013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hildesheim A and Wang SS: Host and viral
genetics and risk of cervical cancer: A review. Virus Res.
89:229–240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sakuragi N: Up-to-date management of lymph
node metastasis and the role of tailored lymphadenectomy in
cervical cancer. Int J Clin Oncol. 12:165–175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mayr NA, Huang Z, Wang JZ, Lo SS, Fan JM,
Grecula JC, Sammet S, Sammet CL, Jia G, Zhang J, et al:
Characterizing tumor heterogeneity with functional imaging and
quantifying high-risk tumor volume for early prediction of
treatment outcome: Cervical cancer as a model. Int J Radiat Oncol
Biol Phys. 83:972–979. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aigner A: MicroRNAs (miRNAs) in cancer
invasion and metastasis: Therapeutic approaches based on
metastasis-related miRNAs. J Mol Med (Berl). 89:445–457. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cho WC: MicroRNAs: Potential biomarkers
for cancer diagnosis, prognosis and targets for therapy. Int J
Biochem Cell Biol. 42:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang H, Lu Y, Wang S, Sheng X and Zhang
S: MicroRNA-152 acts as a tumor suppressor microRNA by inhibiting
Kruppel-like factor 5 in human cervical cancer. Oncol Res.
27:335–340. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu LM, Wang WW, Qi R, Leng TG and Zhang
XL: MicroRNA-224 inhibition prevents progression of cervical
carcinoma by targeting PTX3. J Cell Biochem. 119:10278–10290. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang Y, Hou R, Li S, Li S and Dang G:
MicroRNA-302 inhibits cell migration and invasion in cervical
cancer by targeting DCUN1D1. Exp Ther Med. 16:1000–1008.
2018.PubMed/NCBI
|
|
13
|
Chen Z, Zhang M, Qiao Y, Yang J and Yin Q:
MicroRNA-1297 contributes to the progression of human cervical
carcinoma through PTEN. Artif Cells Nanomed Biotechnol 46 (Sup2).
S1120–S1126. 2018. View Article : Google Scholar
|
|
14
|
Srivastava SK, Ahmad A, Zubair H, Miree O,
Singh S, Rocconi RP, Scalici J and Singh AP: MicroRNAs in
gynecological cancers: Small molecules with big implications.
Cancer Lett. 407:123–138. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan TH, Qiu C, Sun J and Li WH: MiR-877-5p
suppresses cell growth, migration and invasion by targeting cyclin
dependent kinase 14 and predicts prognosis in hepatocellular
carcinoma. Eur Rev Med Pharmacol Sci. 22:3038–3046. 2018.PubMed/NCBI
|
|
16
|
Huang X, Qin J and Lu S: Up-regulation of
miR-877 induced by paclitaxel inhibits hepatocellular carcinoma
cell proliferation though targeting FOXM1. Int J Clin Exp Pathol.
8:1515–1524. 2015.PubMed/NCBI
|
|
17
|
Shi Q, Xu X, Liu Q, Luo F, Shi J and He X:
MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K
in renal cell carcinoma. Oncol Lett. 11:1474–1480. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Berek JS, Matsuo K, Grubbs BH, Gaffney DK,
Lee SI, Kilcoyne A, Cheon GJ, Yoo CW, Li L, Shao Y, et al:
Multidisciplinary perspectives on newly revised 2018 FIGO staging
of cancer of the cervix uteri. J Gynecol Oncol. 30:e402019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou X, Xu CJ, Wang JX, Dai T, Ye YP, Cui
YM, Liao WT, Wu XL and Ou JP: Metastasis-associated in colon
cancer-1 associates with poor prognosis and promotes cell invasion
and angiogenesis in human cervical Cancer. Int J Gynecol Cancer.
25:1353–1363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo L, Lu W, Zhang X, Luo D and Zhang H:
Metastasis-associated colon cancer-1 is a novel prognostic marker
for cervical cancer. Int J Clin Exp Pathol. 7:4150–4155.
2014.PubMed/NCBI
|
|
22
|
Chai H and Yang Y: Effects of MACC1 siRNA
on biological behaviors of HeLa. Arch Gynecol Obstet.
289:1271–1280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen XP, Ren XP, Lan JY, Chen YG and Shen
ZJ: Analysis of HGF, MACC1, C-met and apoptosis-related genes in
cervical carcinoma mice. Mol Biol Rep. 41:1247–1256. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hua F, Xia Y, Wang H, Chen R, Ren Y, Yang
J and Liang W: Effects of small interfering RNA silencing MACC-1
expression on cell proliferation, cell cycle and invasion ability
of cervical cancer SiHa cells. Zhonghua Zhong Liu Za Zhi.
36:496–500. 2014.(In Chinese). PubMed/NCBI
|
|
25
|
Hua FF, Liu SS, Zhu LH, Wang YH, Liang X,
Ma N and Shi HR: MiRNA-338-3p regulates cervical cancer cells
proliferation by targeting MACC1 through MAPK signaling pathway.
Eur Rev Med Pharmacol Sci. 21:5342–5352. 2017.PubMed/NCBI
|
|
26
|
Wang F, Li B and Xie X: The roles and
clinical significance of microRNAs in cervical cancer. Histol
Histopathol. 31:131–139. 2016.PubMed/NCBI
|
|
27
|
Servín-González LS, Granados-López AJ and
López JA: Families of microRNAs expressed in clusters regulate cell
signaling in cervical cancer. Int J Mol Sci. 16:12773–12790. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Díaz-González Sdel M, Deas J,
Benítez-Boijseauneau O, Gómez-Cerón C, Bermúdez-Morales VH,
Rodríguez-Dorantes M, Pérez-Plasencia C and Peralta-Zaragoza O:
Utility of microRNAs and siRNAs in cervical carcinogenesis. Biomed
Res Int. 2015:3749242015.PubMed/NCBI
|
|
29
|
Pedroza-Torres A, López-Urrutia E,
Garcia-Castillo V, Jacobo-Herrera N, Herrera LA, Peralta-Zaragoza
O, López-Camarillo C, De Leon DC, Fernández-Retana J, Cerna-Cortés
JF and Pérez-Plasencia C: MicroRNAs in cervical cancer: Evidences
for a miRNA profile deregulated by HPV and its impact on
radio-resistance. Molecules. 19:6263–6281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li JH, Zhang Z, Du MZ, Guan YC, Yao JN, Yu
HY, Wang BJ, Wang XL, Wu SL and Li Z: microRNA-141-3p fosters the
growth, invasion, and tumorigenesis of cervical cancer cells by
targeting FOXA2. Arch Biochem Biophys. 657:23–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shang A, Zhou C, Bian G, Chen W, Lu W,
Wang W and Li D: miR-381-3p restrains cervical cancer progression
by downregulating FGF7. J Cell Biochem. 120:778–789. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cai N, Hu L, Xie Y, Gao JH, Zhai W, Wang
L, Jin QJ, Qin CY and Qiang R: MiR-17-5p promotes cervical cancer
cell proliferation and metastasis by targeting transforming growth
factor-β receptor 2. Eur Rev Med Pharmacol Sci. 22:1899–1906.
2018.PubMed/NCBI
|
|
33
|
Yang T, Kong B, Kuang YQ, Cheng L, Gu JW,
Zhang JH, Shu HF, Yu SX, He WQ, Xing XM and Huang HD:
Overexpression of MACC1 protein and its clinical implications in
patients with glioma. Tumour Biol. 35:815–819. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang Y, Zhang H, Cai J, Fang L, Wu J, Ye
C, Zhu X and Li M: Overexpression of MACC1 and Its significance in
human breast cancer progression. Cell Biosci. 3:162013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun DW, Zhang YY, Qi Y, Liu GQ, Chen YG,
Ma J and Lv GY: Prognostic and clinicopathological significance of
MACC1 expression in hepatocellular carcinoma patients: A
meta-analysis. Int J Clin Exp Med. 8:4769–4777. 2015.PubMed/NCBI
|
|
36
|
Jin Z, Xu N, Guo K, Xu P, Li P, Zhang Y,
Li X, Zheng S, Liu C, Xu A and Huang P: Increased expression of
metastasis-associated in colon cancer-1 in renal cell carcinoma is
associated with poor prognosis. Int J Clin Exp Pathol. 8:3857–3863.
2015.PubMed/NCBI
|
